Amgen(US:AMGN) ZACKS·2025-10-13 17:11Core Insights - Amgen (AMGN) has a strong history of beating earnings estimates and is well-positioned for continued success in its upcoming quarterly report [1][2] Earnings Performance - Amgen has consistently exceeded earnings expectations, with an average surprise of 16.12% over the last two quarters [2] - In the most recent quarter, Amgen reported earnings of $6.02 per share, surpassing the expected $5.26 by 14.45% [2] - For the previous quarter, the company reported $4.90 per share against an estimate of $4.16, resulting in a surprise of 17.79% [2] Earnings Estimates and Predictions - Recent estimates for Amgen have been revised upward, indicating positive sentiment among analysts [5] - The Zacks Earnings ESP for Amgen is currently +2.44%, suggesting bullish expectations for near-term earnings [8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) indicates a high likelihood of another earnings beat [5][8] Statistical Insights - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6] - The Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7] Upcoming Events - Amgen's next earnings report is anticipated to be released on November 4, 2025 [8]